Elanco Animal Health Incorporated
ELAN
$24.88
-$1.21-4.64%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -168.64% | -82.44% | 134.58% | 128.65% | 127.46% |
| Total Depreciation and Amortization | 4.34% | 8.55% | 4.85% | -0.80% | -2.81% |
| Total Amortization of Deferred Charges | -22.50% | -58.33% | -50.00% | -39.06% | -25.93% |
| Total Other Non-Cash Items | 102.14% | 98.82% | -157.49% | -154.53% | -154.87% |
| Change in Net Operating Assets | -33.56% | -129.29% | 561.11% | 334.21% | 149.67% |
| Cash from Operations | 3.51% | 20.73% | 2.69% | 27.99% | 99.63% |
| Capital Expenditure | -87.76% | -85.11% | -59.85% | -34.29% | -5.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -1,266.67% | -1,266.67% | -115.79% |
| Divestitures | -99.34% | -99.34% | 1,874.24% | 1,874.24% | -- |
| Other Investing Activities | 14.29% | -100.00% | -650.00% | -- | -40.00% |
| Cash from Investing | -124.09% | -125.14% | 1,652.24% | 1,480.52% | 785.21% |
| Total Debt Issued | 313.33% | -5.26% | 5.26% | 44.00% | -5.00% |
| Total Debt Repaid | -42.74% | 60.39% | -141.65% | -173.67% | -202.07% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,794.12% | 191.30% | 1,775.00% | -76.92% | -183.33% |
| Cash from Financing | 81.57% | 81.93% | -254.81% | -397.54% | -1,697.59% |
| Foreign Exchange rate Adjustments | 178.02% | -42.86% | 48.00% | -43.33% | -658.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.62% | -87.60% | 151.02% | 425.93% | 1,557.14% |